Onepot AI raises $13M to rebuild chemical drug synthesis from scratch
The startup is tackling the bottleneck in drug discovery: actually making the molecules. Their AI-driven approach could make compound synthesis twice as fast, expanding what’s possible in pharmaceutical development.













































